Vasquez B, Flock E V, Savage P J, Nagulesparan M, Bennion L J, Baird H R, Bennett P H
Diabetologia. 1984 Feb;26(2):127-33. doi: 10.1007/BF00281119.
To determine whether sustained control of hyperglycaemia in Type 2 (non-insulin-dependent) diabetic patients would diminish proteinuria, the effect of hypocaloric diet therapy (500 kcal/day) on proteinuria was assessed in obese, Type 2 diabetic patients (n = 24) and compared with results obtained for obese subjects with normal glucose tolerance (n = 7) and impaired glucose tolerance (n = 6). Diet therapy of similar mean duration resulted in similar percentage weight loss (mean percentage of original weight +/- SEM) in diabetic (13.6 +/- 1.6%), glucose intolerant (16.4 +/- 3.3%) and obese non-diabetic (11.0 +/- 1.0%) subjects. Following therapy, plasma glucose concentrations 2h after an oral glucose load declined in the diabetic (18.34 +/- 0.81 to 10.67 +/- 0.50 mmol/l, mean +/- SEM; p less than 0.001) and in the glucose intolerant subjects (10.2 +/- 0.3 to 7.3 +/- 0.4 mmol/l, p less than 0.01) while remaining unchanged in the obese non-diabetic subjects (7.09 +/- 0.23 to 6.77 +/- 0.32 mmol/l, NS). Concentrations of total protein of plasma origin and albumin in 24-h urine collections were quantified by a sensitive immunonephelometric assay using specific antisera. Initially, 24-h excretion of total protein and albumin were elevated in the diabetic [mg protein/24 h; (median +/- 95% confidence limits): 63 (42-138), p less than 0.05; albumin: 26 (14-56), p less than 0.05] and glucose intolerant subjects [protein: 52 (13-92), NS; albumin: 24 (3-61), NS] compared with the non-diabetic subjects [protein: 20 (5-38); albumin: 6.2 (3.5-9.5)].(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定2型(非胰岛素依赖型)糖尿病患者高血糖的持续控制是否会减少蛋白尿,我们评估了低热量饮食疗法(500千卡/天)对肥胖的2型糖尿病患者(n = 24)蛋白尿的影响,并与葡萄糖耐量正常的肥胖受试者(n = 7)和葡萄糖耐量受损的受试者(n = 6)的结果进行了比较。相似平均疗程的饮食疗法导致糖尿病患者(13.6 +/- 1.6%)、葡萄糖不耐受患者(16.4 +/- 3.3%)和肥胖非糖尿病患者(11.0 +/- 1.0%)体重减轻的百分比相似。治疗后,糖尿病患者(口服葡萄糖负荷后2小时血浆葡萄糖浓度从18.34 +/- 0.81降至10.67 +/- 0.50毫摩尔/升,平均值 +/- 标准误;p < 0.001)和葡萄糖不耐受患者(从10.2 +/- 0.3降至7.3 +/- 0.4毫摩尔/升,p < 0.01)口服葡萄糖负荷后2小时的血浆葡萄糖浓度下降,而肥胖非糖尿病患者(从7.09 +/- 0.23降至6.77 +/- 0.32毫摩尔/升,无显著性差异)保持不变。使用特异性抗血清通过灵敏的免疫比浊法对24小时尿液收集物中血浆来源的总蛋白和白蛋白浓度进行定量。最初,糖尿病患者[毫克蛋白/24小时;(中位数 +/- 95%置信区间):63(42 - 138),p < 0.05;白蛋白:26(14 - 56),p < 0.05]和葡萄糖不耐受患者[蛋白:52(13 - 92),无显著性差异;白蛋白:24(3 - 61),无显著性差异]24小时总蛋白和白蛋白排泄量高于非糖尿病患者[蛋白:20(5 - 38);白蛋白:6.2(3.5 - 9.5)]。(摘要截短至250字)